225 related articles for article (PubMed ID: 38762719)
1. Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity.
Boutari C; Stefanakis K; Simati S; Guatibonza-García V; Valenzuela-Vallejo L; Anastasiou IA; Connelly MA; Kokkinos A; Mantzoros CS
Cardiovasc Diabetol; 2024 May; 23(1):174. PubMed ID: 38762719
[TBL] [Abstract][Full Text] [Related]
2. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
[TBL] [Abstract][Full Text] [Related]
3. Plasma GDF15 levels are similar between subjects after bariatric surgery and matched controls and are unaffected by meals.
Martinussen C; Svane MS; Bojsen-Møller KN; Jensen CZ; Kristiansen VB; Bookout AL; Jørgensen SB; Holst JJ; Wewer Albrechtsen NJ; Madsbad S; Kuhre RE
Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E443-E452. PubMed ID: 34370594
[TBL] [Abstract][Full Text] [Related]
4. Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease.
Jensen AH; Ytting H; Werge MP; Rashu EB; Hetland LE; Thing M; Nabilou P; Burisch J; Bojsen-Møller KN; Junker AE; Hobolth L; Mortensen C; Tofteng F; Bendtsen F; Møller S; Vyberg M; Serizawa RR; Gluud LL; Wewer Albrechtsen NJ
Am J Physiol Gastrointest Liver Physiol; 2024 Jun; 326(6):G736-G746. PubMed ID: 38625142
[TBL] [Abstract][Full Text] [Related]
5. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
[TBL] [Abstract][Full Text] [Related]
6. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
[TBL] [Abstract][Full Text] [Related]
7. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
Musso G; Gambino R; Pacini G; De Michieli F; Cassader M
Am J Clin Nutr; 2009 Feb; 89(2):558-67. PubMed ID: 19141695
[TBL] [Abstract][Full Text] [Related]
8. Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
Richter MM; Kemp IM; Heebøll S; Winther-Sørensen M; Kjeldsen SAS; Jensen NJ; Nybing JD; Linden FH; Høgh-Schmidt E; Boesen MP; Madsbad S; Schiødt FV; Nørgaard K; Schmidt S; Gluud LL; Haugaard SB; Holst JJ; Nielsen S; Rungby J; Wewer Albrechtsen NJ
Metabolism; 2024 Jul; 156():155915. PubMed ID: 38631460
[TBL] [Abstract][Full Text] [Related]
9. Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss.
Jones IR; Owens DR; Luzio SD; Hayes TM
Diabete Metab; 1989; 15(1):11-22. PubMed ID: 2721810
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity.
Schernthaner-Reiter MH; Kasses D; Tugendsam C; Riedl M; Peric S; Prager G; Krebs M; Promintzer-Schifferl M; Clodi M; Luger A; Vila G
Eur J Endocrinol; 2016 Dec; 175(6):623-631. PubMed ID: 27926473
[TBL] [Abstract][Full Text] [Related]
11. Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.
Bonde L; Vilsbøll T; Nielsen T; Bagger JI; Svare JA; Holst JJ; Larsen S; Knop FK
Diabetes Obes Metab; 2013 Aug; 15(8):713-20. PubMed ID: 23406269
[TBL] [Abstract][Full Text] [Related]
12. Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state.
Meek CL; Lewis HB; Burling K; Reimann F; Gribble F
Ann Clin Biochem; 2021 Mar; 58(2):108-116. PubMed ID: 33175577
[TBL] [Abstract][Full Text] [Related]
13. 24-h severe energy restriction impairs postprandial glycaemic control in young, lean males.
Clayton DJ; Biddle J; Maher T; Funnell MP; Sargeant JA; King JA; Hulston CJ; Stensel DJ; James LJ
Br J Nutr; 2018 Nov; 120(10):1107-1116. PubMed ID: 30401004
[TBL] [Abstract][Full Text] [Related]
14. Prior exercise and postprandial incretin responses in lean and obese individuals.
Heden TD; Liu Y; Kearney ML; Park Y; Dellsperger KC; Thomas TR; Kanaley JA
Med Sci Sports Exerc; 2013 Oct; 45(10):1897-905. PubMed ID: 23559122
[TBL] [Abstract][Full Text] [Related]
15. Enhanced GIP Secretion in Obesity Is Associated with Biochemical Alteration and miRNA Contribution to the Development of Liver Steatosis.
Góralska J; Raźny U; Polus A; Dziewońska A; Gruca A; Zdzienicka A; Dembińska-Kieć A; Solnica B; Micek A; Kapusta M; Słowińska-Solnica K; Malczewska-Malec M
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069846
[TBL] [Abstract][Full Text] [Related]
16. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
17. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
[TBL] [Abstract][Full Text] [Related]
18. The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial.
Smith K; Taylor GS; Allerton DM; Brunsgaard LH; Bowden Davies KA; Stevenson EJ; West DJ
Front Endocrinol (Lausanne); 2021; 12():696977. PubMed ID: 34220720
[TBL] [Abstract][Full Text] [Related]
19. GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism.
Schernthaner-Reiter MH; Itariu BK; Krebs M; Promintzer-Schifferl M; Stulnig TM; Tura A; Anderwald CH; Clodi M; Ludvik B; Pacini G; Luger A; Vila G
Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):334-342. PubMed ID: 30718144
[TBL] [Abstract][Full Text] [Related]
20. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
